A Study to Assess Electrocardiogram Results in Healthy Volunteers Receiving Canagliflozin (JNJ-28431754)

NCT01787357 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Canagliflozin (JNJ-28431754)
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.